Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2005-004984-43Phase 4Completed
Phase 4, randomised, double-blind trial in exercise-induced bronchospasm (EIB) comparing Montelukast with Placebo (2 arms). Primary endpoint: Maximal percentage fall in FEV1 from baseline. Started Jan 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2005-004984-43.